| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 11.712.926.784 $ | +2.413.942.535 $ | +46,2 % | 83 | 10.049.752.600 $ | +774.434.625 $ | +636,5 % | 87 | 9.983.316.876 $ | +3.036.211.691 $ | +39,5 % | 90 | 8.116.139.085 $ | +1.545.118.217 $ | +41,5 % | 73 | ||||
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Sehr schwach | 1.070.510.235 $ | +26.874.901 $ | +2,6 % | 1 | 1.043.635.334 $ | -117.368.354 $ | -10,1 % | 1 | 1.161.003.688 $ | +246.579.209 $ | +27,0 % | 1 | 914.424.479 $ | +311.055.045 $ | +51,6 % | 1 |
| INSMED Inc | INSM | → 0 | Schwach | 516.347.866 $ | -275.559.872 $ | -34,8 % | 1 | 791.907.738 $ | -50.946.923 $ | -6,0 % | 1 | 842.854.661 $ | +398.647.463 $ | +89,7 % | 1 | 444.207.198 $ | +133.777.281 $ | +43,1 % | 1 |
| ARGENX SE | ARGX | → 0 | Schwach | 658.202.715 $ | +140.129.773 $ | +27,0 % | 1 | 518.072.942 $ | -48.304.360 $ | -8,5 % | 1 | 566.377.302 $ | +69.632.855 $ | +14,0 % | 1 | 496.744.447 $ | +125.499.431 $ | +33,8 % | 1 |
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Stark | 631.875.072 $ | +104.111.818 $ | +19,7 % | 1 | 527.763.254 $ | -60.654.429 $ | -10,3 % | 1 | 588.417.683 $ | +113.020.194 $ | +23,8 % | 1 | 475.397.489 $ | +97.062.580 $ | +25,7 % | 1 |
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 620.398.832 $ | +87.174.646 $ | +16,3 % | 1 | 533.224.186 $ | +91.366.497 $ | +20,7 % | 1 | 441.857.689 $ | +59.468.208 $ | +15,6 % | 1 | 382.389.481 $ | +64.240.051 $ | +20,2 % | 1 |
| CG Oncology, Inc. | CGON | → 0 | Neutral | 604.961.620 $ | +132.229.815 $ | +28,0 % | 1 | 472.731.805 $ | +389.188.292 $ | +465,9 % | 1 | 83.543.513 $ | +15.018.533 $ | +21,9 % | 1 | 68.524.980 $ | +24.293.364 $ | +54,9 % | 1 |
| Avidity Biosciences, Inc. | RNA | → 0 | 495.514.160 $ | +222.338.962 $ | +81,4 % | 1 | |||||||||||||
| Tango Therapeutics, Inc. | TNGX | → 0 | Schwach | 434.533.381 $ | +156.284.411 $ | +56,2 % | 1 | 278.248.970 $ | +265.036.690 $ | +2.006,0 % | 1 | 13.212.280 $ | +13.212.280 $ | 1 | |||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 377.492.205 $ | +167.056.727 $ | +79,4 % | 1 | 210.435.478 $ | +73.760.889 $ | +54,0 % | 1 | 136.674.589 $ | +75.969.936 $ | +125,1 % | 1 | 60.704.653 $ | +6.483.373 $ | +12,0 % | 1 |
| Celcuity Inc. | CELC | → 0 | Neutral | 345.758.952 $ | -1.183.389 $ | -0,3 % | 1 | 346.942.341 $ | +292.069.383 $ | +532,3 % | 1 | 54.872.958 $ | +54.872.958 $ | 1 | |||||
| Natera, Inc. | NTRA | → 0 | Schwach | 271.450.000 $ | +21.462.500 $ | +8,6 % | 1 | 249.987.500 $ | -93.647.500 $ | -27,3 % | 1 | 343.635.000 $ | +21.695.000 $ | +6,7 % | 1 | 321.940.000 $ | -116.230.386 $ | -26,5 % | 1 |
| Erasca, Inc. | ERAS | → 0 | Neutral | 328.784.533 $ | +67.361.441 $ | +25,8 % | 1 | 261.423.092 $ | +260.877.550 $ | +47.819,9 % | 1 | 545.542 $ | +545.542 $ | 1 | |||||
| RadNet, Inc. | RDNT | → 0 | Neutral | 298.911.900 $ | +59.423.250 $ | +24,8 % | 1 | 239.488.650 $ | -41.523.325 $ | -14,8 % | 1 | 281.011.975 $ | +66.439.367 $ | +31,0 % | 1 | 214.572.608 $ | +61.465.131 $ | +40,1 % | 1 |
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 298.741.485 $ | +197.789.326 $ | +195,9 % | 1 | 100.952.159 $ | +38.569.693 $ | +61,8 % | 1 | 62.382.466 $ | +24.967.636 $ | +66,7 % | 1 | 37.414.830 $ | +15.604.105 $ | +71,5 % | 1 |
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Schwach | 211.293.293 $ | -23.430.361 $ | -10,0 % | 1 | 234.723.654 $ | -38.372.348 $ | -14,1 % | 1 | 273.096.002 $ | +84.260.981 $ | +44,6 % | 1 | 188.835.021 $ | +62.780.864 $ | +49,8 % | 1 |
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 89.359.113 $ | -120.745.288 $ | -57,5 % | 1 | 210.104.401 $ | -59.571.999 $ | -22,1 % | 1 | 269.676.400 $ | +219.883.301 $ | +441,6 % | 1 | 49.793.099 $ | +49.793.099 $ | 1 | |
| Penumbra Inc | PEN | → 0 | Neutral | 269.403.204 $ | +49.901.677 $ | +22,7 % | 1 | 219.501.527 $ | -2.112.079 $ | -1,0 % | 1 | ||||||||
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Neutral | 260.338.324 $ | +183.896.069 $ | +240,6 % | 1 | 76.442.255 $ | +7.439.058 $ | +10,8 % | 1 | 69.003.197 $ | -29.005.444 $ | -29,6 % | 1 | 98.008.641 $ | +35.927.504 $ | +57,9 % | 1 |
| Akero Therapeutics, Inc. | → 0 | 260.074.596 $ | -32.208.059 $ | -11,0 % | 1 | ||||||||||||||
| iRhythm Holdings, Inc. | IRTC | → 0 | Neutral | 259.623.957 $ | +62.707.587 $ | +31,8 % | 1 | 196.916.370 $ | -12.815.936 $ | -6,1 % | 1 | 209.732.306 $ | +209.732.306 $ | 1 | |||||
| uniQure N.V. | QURE | → 0 | Neutral | 181.548.806 $ | +139.261.885 $ | +329,3 % | 1 | 42.286.921 $ | -46.528.365 $ | -52,4 % | 1 | 88.815.286 $ | -169.470.096 $ | -65,6 % | 1 | 258.285.382 $ | +186.379.642 $ | +259,2 % | 1 |
| CYTOKINETICS INC | CYTK | → 0 | Neutral | 243.814.036 $ | +64.462.512 $ | +35,9 % | 1 | 179.351.524 $ | +6.449.145 $ | +3,7 % | 1 | 172.902.379 $ | +23.347.535 $ | +15,6 % | 1 | 149.554.844 $ | +59.647.784 $ | +66,3 % | 1 |
| Kailera Therapeutics, Inc. | KLRA | → 0 | Stark | 237.413.345 $ | +237.413.345 $ | 1 | |||||||||||||
| Apogee Therapeutics, Inc. | APGE | → 0 | 234.169.104 $ | +29.460.022 $ | +14,4 % | 1 | 204.709.082 $ | +96.957.468 $ | +90,0 % | 1 | 107.751.614 $ | -10.034.759 $ | -8,5 % | 1 | |||||
| ESTABLISHMENT LABS HOLDINGS INC. | ESTA | → 0 | Neutral | 227.885.188 $ | +77.094.826 $ | +51,1 % | 1 | 150.790.362 $ | -37.883.641 $ | -20,1 % | 1 | 188.674.003 $ | +82.557.820 $ | +77,8 % | 1 | 106.116.183 $ | -4.252.052 $ | -3,9 % | 1 |
| Guardant Health, Inc. | GH | → 0 | Neutral | 222.199.381 $ | +85.396.363 $ | +62,4 % | 1 | 136.803.018 $ | -14.469.693 $ | -9,6 % | 1 | 151.272.711 $ | +58.737.769 $ | +63,5 % | 1 | 92.534.942 $ | +47.962.630 $ | +107,6 % | 1 |
| NEUROCRINE BIOSCIENCES INC | NBIX | → 0 | Stark | 213.689.740 $ | +73.772.375 $ | +52,7 % | 1 | 139.917.365 $ | -10.716.307 $ | -7,1 % | 1 | 150.633.672 $ | +1.540.005 $ | +1,0 % | 1 | 149.093.667 $ | +15.601.837 $ | +11,7 % | 1 |
| Apellis Pharmaceuticals, Inc. | APLS | → 0 | 148.249.360 $ | -44.339.752 $ | -23,0 % | 1 | 192.589.112 $ | +192.589.112 $ | 1 | ||||||||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Stark | 180.756.457 $ | +21.719.353 $ | +13,7 % | 1 | 159.037.104 $ | -31.793.132 $ | -16,7 % | 1 | 190.830.236 $ | +38.366.094 $ | +25,2 % | 1 | 152.464.142 $ | -41.569.807 $ | -21,4 % | 1 |
| Merus N.V. | → 0 | 190.679.830 $ | -19.749.258 $ | -9,4 % | 1 | ||||||||||||||
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 184.001.738 $ | +899.764 $ | +0,5 % | 1 | 183.101.974 $ | +7.044.765 $ | +4,0 % | 1 | 176.057.209 $ | +55.654.371 $ | +46,2 % | 1 | 120.402.838 $ | +62.250.829 $ | +107,0 % | 1 |
| STRYKER CORP | SYK | → 0 | Neutral | 32.859.000 $ | -53.251.150 $ | -61,8 % | 1 | 86.110.150 $ | -95.028.150 $ | -52,5 % | 1 | 181.138.300 $ | -52.487.941 $ | -22,5 % | 1 | ||||
| Immunocore Holdings plc | IMCR | → 0 | Schwach | 154.616.087 $ | +7.791.677 $ | +5,3 % | 1 | 146.824.410 $ | -22.206.279 $ | -13,1 % | 1 | 169.030.689 $ | -7.889.072 $ | -4,5 % | 1 | 176.919.761 $ | +24.105.500 $ | +15,8 % | 1 |
| REPLIGEN CORP | RGEN | → 0 | Neutral | 169.272.512 $ | +27.181.592 $ | +19,1 % | 1 | 142.090.920 $ | -32.256.120 $ | -18,5 % | 1 | 174.347.040 $ | +174.347.040 $ | 1 | |||||
| UroGen Pharma Ltd. | URGN | → 0 | Neutral | 167.215.336 $ | +85.516.104 $ | +104,7 % | 1 | 81.699.232 $ | -24.718.789 $ | -23,2 % | 1 | 106.418.021 $ | +15.767.316 $ | +17,4 % | 1 | 90.650.705 $ | +28.399.343 $ | +45,6 % | 1 |
| Axsome Therapeutics, Inc. | AXSM | → 0 | Schwach | 162.184.503 $ | +26.296.163 $ | +19,4 % | 1 | 135.888.340 $ | -22.461.164 $ | -14,2 % | 1 | ||||||||
| GH Research PLC | GHRS | → 0 | Neutral | 159.500.947 $ | +76.071.508 $ | +91,2 % | 1 | 83.429.439 $ | +8.069.988 $ | +10,7 % | 1 | 75.359.451 $ | -4.285.314 $ | -5,4 % | 1 | 79.644.765 $ | +12.106.594 $ | +17,9 % | 1 |
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 151.418.782 $ | +92.621.665 $ | +157,5 % | 1 | 58.797.117 $ | -1.628.874 $ | -2,7 % | 1 | 60.425.991 $ | +10.532.646 $ | +21,1 % | 1 | 49.893.345 $ | +26.871.944 $ | +116,7 % | 1 |
| Immatics N.V. | IMTX | → 0 | Schwach | 131.144.763 $ | +4.510.457 $ | +3,6 % | 1 | 126.634.306 $ | +6.584.089 $ | +5,5 % | 1 | 120.050.217 $ | +44.941.160 $ | +59,8 % | 1 | 75.109.057 $ | +37.609.639 $ | +100,3 % | 1 |
| Zai Lab Ltd | ZLAB | → 0 | Schwach | 124.906.608 $ | +1.249.066 $ | +1,0 % | 1 | 123.657.542 $ | +900.218 $ | +0,7 % | 1 | 122.757.324 $ | +45.102.727 $ | +58,1 % | 1 | 77.654.597 $ | -115.969.957 $ | -59,9 % | 1 |
| Immunovant, Inc. | IMVT | → 0 | Neutral | 122.442.522 $ | +43.504.753 $ | +55,1 % | 1 | 78.937.769 $ | -1.843.178 $ | -2,3 % | 1 | 80.780.947 $ | +80.780.947 $ | 1 | |||||
| BELITE BIO, INC | BLTE | → 0 | Schwach | 110.150.398 $ | -3.902.136 $ | -3,4 % | 1 | 114.052.534 $ | -371.973 $ | -0,3 % | 1 | 114.424.507 $ | +91.299.507 $ | +394,8 % | 1 | 23.125.000 $ | +23.125.000 $ | 1 | |
| Xencor Inc | XNCR | → 0 | Schwach | 109.117.122 $ | +27.380.942 $ | +33,5 % | 1 | 81.736.180 $ | -22.026.748 $ | -21,2 % | 1 | 103.762.928 $ | +30.789.965 $ | +42,2 % | 1 | 72.972.963 $ | +54.086.303 $ | +286,4 % | 1 |
| INTUITIVE SURGICAL INC | ISRG | → 0 | Neutral | 101.417.800 $ | +44.086.310 $ | +76,9 % | 1 | 57.331.490 $ | -33.212.907 $ | -36,7 % | 1 | 90.544.397 $ | -19.472.218 $ | -17,7 % | 1 | ||||
| MASIMO CORP | MASI | → 0 | 88.869.218 $ | -11.950.812 $ | -11,9 % | 1 | 100.820.030 $ | -14.123.687 $ | -12,3 % | 1 | |||||||||
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 92.345.357 $ | +31.194.648 $ | +51,0 % | 1 | 61.150.709 $ | -29.039.925 $ | -32,2 % | 1 | 90.190.634 $ | +10.552.102 $ | +13,2 % | 1 | 79.638.532 $ | +21.838.673 $ | +37,8 % | 1 |
| INSULET CORP | PODD | → 0 | Neutral | 92.264.304 $ | +92.264.304 $ | 1 | |||||||||||||
| Alkermes plc. | ALKS | → 0 | Stark | 87.623.093 $ | +28.488.585 $ | +48,2 % | 1 | 59.134.508 $ | +12.341.987 $ | +26,4 % | 1 | 46.792.521 $ | -3.378.159 $ | -6,7 % | 1 | 50.170.680 $ | -83.789.608 $ | -62,5 % | 1 |
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 86.274.901 $ | +79.319.901 $ | +1.140,5 % | 1 | 6.955.000 $ | +6.955.000 $ | 1 | |||||||||
| CASTLE BIOSCIENCES INC | CSTL | → 0 | Stark | 66.263.290 $ | -1.453.834 $ | -2,1 % | 1 | 67.717.124 $ | -14.565.595 $ | -17,7 % | 1 | 82.282.719 $ | +82.282.719 $ | 1 | |||||
| Replimune Group, Inc. | REPL | → 0 | Sehr schwach | 82.046.202 $ | +25.765.795 $ | +45,8 % | 1 | 56.280.407 $ | -13.123.814 $ | -18,9 % | 1 | 69.404.221 $ | +42.606.104 $ | +159,0 % | 1 | 26.798.117 $ | +7.614.174 $ | +39,7 % | 1 |
| Centessa Pharmaceuticals plc | CNTA | → 0 | 81.591.831 $ | +36.802.998 $ | +82,2 % | 1 | 44.788.833 $ | -10.786.032 $ | -19,4 % | 1 | 55.574.865 $ | +35.472.820 $ | +176,5 % | 1 | |||||
| Beta Bionics, Inc. | BBNX | → 0 | Schwach | 23.505.000 $ | +3.465.000 $ | +17,3 % | 1 | 20.040.000 $ | -56.135.000 $ | -73,7 % | 1 | 76.175.000 $ | +10.620.075 $ | +16,2 % | 1 | 65.554.925 $ | +17.518.704 $ | +36,5 % | 1 |
| Hinge Health, Inc. | HNGE | → 0 | Neutral | 41.500.000 $ | -32.920.800 $ | -44,2 % | 1 | 74.420.800 $ | +58.000.725 $ | +353,2 % | 1 | 16.420.075 $ | +16.420.075 $ | 1 | |||||
| Candel Therapeutics, Inc. | CADL | → 0 | Neutral | 66.146.785 $ | +34.678.897 $ | +110,2 % | 1 | 31.467.888 $ | +31.467.888 $ | 1 | |||||||||
| ROCKET PHARMACEUTICALS, INC. | RCKT | → 0 | Neutral | 60.493.370 $ | -2.836.064 $ | -4,5 % | 1 | 63.329.434 $ | +1.236.849 $ | +2,0 % | 1 | 62.092.585 $ | +4.416.728 $ | +7,7 % | 1 | 57.675.857 $ | +14.330.736 $ | +33,1 % | 1 |
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | 52.712.160 $ | -10.192.065 $ | -16,2 % | 1 | 62.904.225 $ | +26.569.306 $ | +73,1 % | 1 | 36.334.919 $ | +22.903.999 $ | +170,5 % | 1 | |||||
| Kodiak Sciences Inc. | KOD | → 0 | Neutral | 57.969.909 $ | +1.249.865 $ | +2,2 % | 1 | 56.720.044 $ | +15.117.437 $ | +36,3 % | 1 | 41.602.607 $ | +41.602.607 $ | 1 | |||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 55.450.779 $ | +17.526.610 $ | +46,2 % | 1 | 37.924.169 $ | +26.160.177 $ | +222,4 % | 1 | |||||||||
| Aktis Oncology, Inc. | AKTS | → 0 | Stark | 51.311.546 $ | +22.829.897 $ | +80,2 % | 1 | 28.481.649 $ | +28.481.649 $ | 1 | |||||||||
| Verastem, Inc. | VSTM | → 0 | Schwach | 25.348.729 $ | -9.505.693 $ | -27,3 % | 1 | 34.854.422 $ | -15.914.660 $ | -31,3 % | 1 | 50.769.082 $ | +2.854.800 $ | +6,0 % | 1 | 47.914.282 $ | +30.270.076 $ | +171,6 % | 1 |
| QUEST DIAGNOSTICS INC | DGX | → 0 | Stark | 47.645.000 $ | -42.170.000 $ | -47,0 % | 1 | ||||||||||||
| Axogen, Inc. | AXGN | → 0 | Neutral | 46.724.695 $ | +46.724.695 $ | 1 | |||||||||||||
| DANAHER CORP /DE/ | DHR | → 0 | Neutral | 43.810.400 $ | +43.810.400 $ | 1 | |||||||||||||
| Cullinan Therapeutics, Inc. | CGEM | → 0 | Neutral | 43.054.759 $ | +18.813.067 $ | +77,6 % | 1 | 24.241.692 $ | +6.585.006 $ | +37,3 % | 1 | 17.656.686 $ | +7.540.343 $ | +74,5 % | 1 | 10.116.343 $ | -2.729.536 $ | -21,2 % | 1 |
| Neurogene Inc. | NGNE | → 0 | Neutral | 42.849.241 $ | +15.382.128 $ | +56,0 % | 1 | 27.467.113 $ | -599.481 $ | -2,1 % | 1 | 28.066.594 $ | +4.455.232 $ | +18,9 % | 1 | 23.611.362 $ | +3.242.645 $ | +15,9 % | 1 |
| Orchestra BioMed Holdings, Inc. | OBIO | → 0 | Neutral | 41.234.412 $ | +5.933.644 $ | +16,8 % | 1 | 35.300.768 $ | +830.607 $ | +2,4 % | 1 | 34.470.161 $ | +13.871.125 $ | +67,3 % | 1 | 20.599.036 $ | -1.661.210 $ | -7,5 % | 1 |
| Aquestive Therapeutics, Inc. | AQST | → 0 | Sehr schwach | 30.894.119 $ | +74.264 $ | +0,2 % | 1 | 30.819.855 $ | -9.555.145 $ | -23,7 % | 1 | 40.375.000 $ | +5.437.500 $ | +15,6 % | 1 | 34.937.500 $ | +34.937.500 $ | 1 | |
| LENZ Therapeutics, Inc. | LENZ | → 0 | Schwach | 40.216.660 $ | +14.910.728 $ | +58,9 % | 1 | ||||||||||||
| Waystar Holding Corp. | WAY | → 0 | Neutral | 39.299.300 $ | +39.299.300 $ | 1 | |||||||||||||
| Solid Biosciences Inc. | SLDB | → 0 | Neutral | 38.890.331 $ | +38.890.331 $ | 1 | |||||||||||||
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 36.722.261 $ | -2.097.034 $ | -5,4 % | 1 | 38.819.295 $ | +38.819.295 $ | 1 | |||||||||
| Savara Inc | SVRA | → 0 | Stark | 36.666.661 $ | +4.166.666 $ | +12,8 % | 1 | 32.499.995 $ | -3.392.856 $ | -9,5 % | 1 | 35.892.851 $ | +35.892.851 $ | 1 | |||||
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 36.565.673 $ | +20.471.475 $ | +127,2 % | 1 | ||||||||||||
| Evommune, Inc. | EVMN | → 0 | Neutral | 19.964.703 $ | -14.571.680 $ | -42,2 % | 1 | 34.536.383 $ | +12.559.935 $ | +57,2 % | 1 | 21.976.448 $ | +21.976.448 $ | 1 | |||||
| Abivax S.A. | ABVX | → 0 | Neutral | 3.518.064 $ | -26.196.936 $ | -88,2 % | 1 | 29.715.000 $ | +29.715.000 $ | 1 | |||||||||
| GE HealthCare Technologies Inc. | GEHC | → 0 | Stark | 29.551.850 $ | -16.815.970 $ | -36,3 % | 1 | ||||||||||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Neutral | 27.520.800 $ | +7.531.200 $ | +37,7 % | 1 | 19.989.600 $ | +1.315.200 $ | +7,0 % | 1 | 18.674.400 $ | +18.674.400 $ | 1 | |||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Neutral | 24.181.181 $ | +3.363.734 $ | +16,2 % | 1 | 20.817.447 $ | +20.817.447 $ | 1 | |||||||||
| Wave Life Sciences, Inc. | WVE | → 0 | 7.843.500 $ | -1.944.000 $ | -19,9 % | 1 | 9.787.500 $ | -13.162.500 $ | -57,4 % | 1 | 22.950.000 $ | +16.362.000 $ | +248,4 % | 1 | 6.588.000 $ | +738.000 $ | +12,6 % | 1 | |
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 8.053.530 $ | -14.308.752 $ | -64,0 % | 1 | 22.362.282 $ | +9.855.056 $ | +78,8 % | 1 | 12.507.226 $ | -1.971.011 $ | -13,6 % | 1 | ||||
| Compass Therapeutics, Inc. | CMPX | → 0 | Schwach | 22.147.109 $ | +8.722.109 $ | +65,0 % | 1 | 13.425.000 $ | +4.675.000 $ | +53,4 % | 1 | 8.750.000 $ | +8.750.000 $ | 1 | |||||
| Century Therapeutics, Inc. | IPSC | → 0 | Neutral | 21.304.347 $ | +1.652.173 $ | +8,4 % | 1 | 19.652.174 $ | +19.652.174 $ | 1 | |||||||||
| Alector, Inc. | ALEC | → 0 | Neutral | 20.692.786 $ | +20.692.786 $ | 1 | |||||||||||||
| Fulgent Genetics, Inc. | FLGT | → 0 | Neutral | 20.495.100 $ | +1.974.041 $ | +10,7 % | 1 | 18.521.059 $ | +18.521.059 $ | 1 | |||||||||
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 3.446.574 $ | -16.301.186 $ | -82,5 % | 1 | 19.747.760 $ | +9.029.844 $ | +84,2 % | 1 | ||||||||
| Beam Therapeutics Inc. | BEAM | → 0 | Schwach | 19.575.922 $ | +5.983.433 $ | +44,0 % | 1 | 13.592.489 $ | -2.218.833 $ | -14,0 % | 1 | 15.811.322 $ | +15.811.322 $ | 1 | |||||
| Definium Therapeutics, Inc. | DFTX | → 0 | Stark | 18.816.000 $ | +13.146.000 $ | +231,9 % | 1 | 5.670.000 $ | +1.653.000 $ | +41,2 % | 1 | 4.017.000 $ | +4.017.000 $ | 1 | |||||
| EXAGEN INC. | XGN | → 0 | Schwach | 906.750 $ | -278.943 $ | -23,5 % | 1 | 1.185.693 $ | -3.620.316 $ | -75,3 % | 1 | 4.806.009 $ | -13.842.548 $ | -74,2 % | 1 | 18.648.557 $ | +6.804.432 $ | +57,4 % | 1 |
| Heartflow, Inc. | HTFL | → 0 | Neutral | 8.655.300 $ | -3.388.050 $ | -28,1 % | 1 | 12.043.350 $ | -2.385.900 $ | -16,5 % | 1 | 14.429.250 $ | -2.232.450 $ | -13,4 % | 1 | 16.661.700 $ | +16.661.700 $ | 1 | |
| Tempus AI, Inc. | TEM | → 0 | Schwach | 11.810.000 $ | -4.332.000 $ | -26,8 % | 1 | 16.142.000 $ | -9.274.000 $ | -36,5 % | 1 | ||||||||
| IDEAYA Biosciences, Inc. | IDYA | → 0 | Neutral | 13.803.690 $ | +13.803.690 $ | 1 | |||||||||||||
| Avalo Therapeutics, Inc. | AVTX | → 0 | Schwach | 3.234.000 $ | -9.560.443 $ | -74,7 % | 1 | 12.794.443 $ | +12.794.443 $ | 1 | |||||||||
| Ocugen, Inc. | OCGN | → 0 | Neutral | 10.199.999 $ | -1.866.666 $ | -15,5 % | 1 | 12.066.665 $ | +12.066.665 $ | 1 | |||||||||
| Lumexa Imaging Holdings, Inc. | LMRI | → 0 | Stark | 7.332.000 $ | +1.742.000 $ | +31,2 % | 1 | 5.590.000 $ | -6.435.000 $ | -53,5 % | 1 | 12.025.000 $ | +12.025.000 $ | 1 | |||||
| Larimar Therapeutics, Inc. | LRMR | → 0 | Stark | 7.826.297 $ | +1.076.297 $ | +15,9 % | 1 | 6.750.000 $ | -5.156.250 $ | -43,3 % | 1 | 11.906.250 $ | +1.812.500 $ | +18,0 % | 1 | 10.093.750 $ | +10.093.750 $ | 1 | |
| CytomX Therapeutics, Inc. | CTMX | → 0 | Neutral | 11.042.185 $ | +3.184.580 $ | +40,5 % | 1 | ||||||||||||
| Kalaris Therapeutics, Inc. | KLRS | → 0 | Neutral | 5.291.000 $ | -2.210.000 $ | -29,5 % | 1 | 7.501.000 $ | -3.471.000 $ | -31,6 % | 1 | 10.972.000 $ | +10.972.000 $ | 1 | |||||
| AtaiBeckley Inc. | ATAI | → 0 | 10.540.000 $ | +3.460.000 $ | +48,9 % | 1 | 7.080.000 $ | -1.100.000 $ | -13,4 % | 1 | 8.180.000 $ | +8.180.000 $ | 1 | ||||||
| Milestone Pharmaceuticals Inc. | MIST | → 0 | Schwach | 10.496.670 $ | +2.962.779 $ | +39,3 % | 1 | 7.533.891 $ | +2.471.565 $ | +48,8 % | 1 | 5.062.326 $ | +50.122 $ | +1,0 % | 1 | 5.012.204 $ | +150.366 $ | +3,1 % | 1 |
| IQVIA HOLDINGS INC. | IQV | → 0 | Neutral | 10.368.860 $ | +10.368.860 $ | 1 | |||||||||||||
| TENAX THERAPEUTICS, INC. | TENX | → 0 | Schwach | 10.135.094 $ | +4.214.860 $ | +71,2 % | 1 | 5.920.234 $ | +1.308.196 $ | +28,4 % | 1 | 4.612.038 $ | +1.732.825 $ | +60,2 % | 1 | 2.879.213 $ | +699.940 $ | +32,1 % | 1 |
| Freenome, Inc. | PCSC | → 0 | 8.078.400 $ | -66.825 $ | -0,8 % | 1 | 8.145.225 $ | -1.529.550 $ | -15,8 % | 1 | 9.674.775 $ | +1.833.975 $ | +23,4 % | 1 | 7.840.800 $ | -44.550 $ | -0,6 % | 1 | |
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Sehr schwach | 6.020.000 $ | -1.580.000 $ | -20,8 % | 1 | 7.600.000 $ | +385.000 $ | +5,3 % | 1 | 7.215.000 $ | +7.215.000 $ | 1 | |||||
| ALLURION TECHNOLOGIES, INC. | ALUR | → 0 | 7.246.459 $ | +2.034.123 $ | +39,0 % | 1 | 5.212.336 $ | -966.189 $ | -15,6 % | 1 | |||||||||
| Inventiva S.A. | IVA | → 0 | Neutral | 7.207.796 $ | +1.168.836 $ | +19,4 % | 1 | 6.038.960 $ | +6.038.960 $ | 1 | |||||||||
| PepGen Inc. | PEPG | → 0 | Neutral | 6.930.000 $ | +6.930.000 $ | 1 | |||||||||||||
| CRESCENT BIOPHARMA, INC. | CBIO | → 0 | Neutral | 6.711.408 $ | -137.957 $ | -2,0 % | 1 | 6.849.365 $ | +2.427.293 $ | +54,9 % | 1 | 4.422.072 $ | +4.422.072 $ | 1 | |||||
| Allogene Therapeutics, Inc. | ALLO | → 0 | Neutral | 6.760.000 $ | +6.760.000 $ | 1 | |||||||||||||
| 4D Molecular Therapeutics, Inc. | FDMT | → 0 | Neutral | 6.327.302 $ | +1.898.191 $ | +42,9 % | 1 | 4.429.111 $ | +861.083 $ | +24,1 % | 1 | 3.568.028 $ | +3.568.028 $ | 1 | |||||
| Maze Therapeutics, Inc. | MAZE | → 0 | Schwach | 6.326.080 $ | +6.326.080 $ | 1 | |||||||||||||
| Omada Health, Inc. | OMDA | → 0 | Schwach | 2.514.000 $ | -642.000 $ | -20,3 % | 1 | 3.156.000 $ | -1.266.000 $ | -28,6 % | 1 | 4.422.000 $ | +762.000 $ | +20,8 % | 1 | ||||
| Medline Inc. | MDLN | → 0 | Schwach | 2.760.800 $ | -354.200 $ | -11,4 % | 1 | 3.115.000 $ | +175.000 $ | +6,0 % | 1 | 2.940.000 $ | +2.940.000 $ | 1 | |||||
| ImageneBio, Inc. | IMA | → 0 | Neutral | 1.973.226 $ | +301.001 $ | +18,0 % | 1 | 1.672.225 $ | -635.446 $ | -27,5 % | 1 | 2.307.671 $ | -418.056 $ | -15,3 % | 1 | 2.725.727 $ | +2.725.727 $ | 1 | |
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 2.194.200 $ | +276.000 $ | +14,4 % | 1 | 1.918.200 $ | -464.100 $ | -19,5 % | 1 | 2.382.300 $ | +2.382.300 $ | 1 | |||||
| Adagio Medical Holdings, Inc. | ADGM | → 0 | 406.160 $ | +133.991 $ | +49,2 % | 1 | |||||||||||||
| 11.712.926.784 $ | +2.413.942.535 $ | +46,2 % | 83 | 10.049.752.600 $ | +774.434.625 $ | +636,5 % | 87 | 9.983.316.876 $ | +3.036.211.691 $ | +39,5 % | 90 | 8.116.139.085 $ | +1.545.118.217 $ | +41,5 % | 73 | ||||